FRIWO AG (FRA:CEA)

Intra-Cellular Therapies Revenue

FRIWO AG had revenue of 19.30M EUR in the quarter ending March 31, 2025, a decrease of -24.93%. This brings the company's revenue in the last twelve months to 91.62M, down -10.13% year-over-year. In the year 2024, FRIWO AG had annual revenue of 93.02M, down -16.25%.

• Revenue (ttm): 91.62M
• Revenue Growth: -10.13%
• P/S Ratio: 0.71
• Revenue / Employee: 75.97K
• Employees: 1,206
• Market Cap: 65.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	93.02M	-18.05M	-16.25%
Dec 31, 2023	111.08M	-73.79M	-39.92%
Dec 31, 2022	184.87M	84.32M	83.87%
Dec 31, 2021	100.55M	1.19M	1.20%
Dec 31, 2020	99.36M	3.60M	3.76%